Comparative cytotoxicity of chelidonine and homochelidonine, the dimethoxy analogues isolated from Chelidonium majus L. (Papaveraceae), against human leukemic and lung carcinoma cells
- 1 March 2016
- journal article
- Published by Elsevier in Phytomedicine
- Vol. 23 (3) , 253-266
Abstract
No abstract availableKeywords
Funding Information
- University of Pardubice (PRVOUK P37/01)
- Charles University in Prague
- European Social Fund Plus
- Czech Republic (CZ.1.07/2.3.00/30.0058)
This publication has 24 references indexed in Scilit:
- Modulation of multidrug resistance in cancer cells by chelidonine and Chelidonium majus alkaloidsPhytomedicine, 2013
- Chelidonine isolated from ethanolic extract of Chelidonium majus promotes apoptosis in HeLa cells through p38-p53 and PI3K/AKT signalling pathwaysJournal of Chinese Integrative Medicine, 2012
- Identification of molecular and functional patterns of p53 alterations in chronic lymphocytic leukemia patients in different phases of the diseaseHaematologica, 2012
- New Insights into p53 Signaling and Cancer Cell Response to DNA Damage: Implications for Cancer TherapyJournal of Biomedicine and Biotechnology, 2012
- Benzo[c]phenanthridine alkaloids exhibit strong anti-proliferative activity in malignant melanoma cells regardless of their p53 statusJournal of Dermatological Science, 2011
- Chelidonium majus – an Integrative Review: Traditional Knowledge versus Modern FindingsResearch in Complementary Medicine, 2010
- Transcriptional down regulation of hTERT and senescence induction in HepG2 cells by chelidonineWorld Journal of Gastroenterology, 2009
- New Tubulin Inhibitors from Plants – A Critical AssessmentChimia, 2007
- The effects of chelidonine on tubulin polymerisation, cell cycle progression and selected signal transmission pathwaysEuropean Journal of Cell Biology, 2001
- Cocarcinogens of the diterpene ester type fromCroton flavens L. and esophageal cancer in CuraçaoCellular and Molecular Life Sciences, 1978